- London
- Hybrid
- Director
Leads the design and delivery of health economics and outcomes research (HEOR) evidence for a portfolio of HIV treatment and prevention medicines, spanning real-world evidence, clinical outcome assessments, evidence synthesis and economic modelling. Sets COA and patient-centred outcomes strategy, partners with R&D, medical affairs, market access and external payers/HTA bodies, and oversees study quality, compliance and budget within a matrix organisation.